Australian Clinical Labs Ltd (AU:ACL) has released an update.
UBS Group AG has become a substantial holder in Australian Clinical Labs Limited with a 5.17% voting power after acquiring over 10 million shares. This position was achieved through various bodies corporate and custodians, with UBS AG Australia Branch, UBS AG London Branch, and UBS Asset Management (Australia) Ltd among the notable entities exercising control over the shares. The financial details of the transactions leading to this ownership stake are detailed in the appendix of the original document.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.